We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$368M
2
CSCO icon
Cisco
CSCO
+$131M
3
WMT icon
Walmart Inc
WMT
+$109M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$93.1M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$87.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$124M
2
PX
Praxair Inc
PX
+$110M
3
KHC icon
Kraft Heinz
KHC
+$86.3M
4
XNTK icon
State Street SPDR NYSE Technology ETF
XNTK
+$67.4M
5
PSA icon
Public Storage
PSA
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
3451
CALL
JPMorgan Chase
JPM
$956B
$7K ﹤0.01%
169,200
+27,100
+19% +$2.89M
WMT icon
3452
CALL
Walmart Inc
WMT
$897B
$7K ﹤0.01%
138,000
+62,400
+83% +$2M
SGI
3453
CALL
Somnigroup International
SGI
$13.6B
$7K ﹤0.01%
138,400
-4,000
-3% -$47.9K
ALXN
3454
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$7K ﹤0.01%
+11,300
New +$1.34M
ONCS
3455
DELISTED
OncoSec Medical Incorporated
ONCS
$7K ﹤0.01%
+47
New +$11.8K
ATNM icon
3456
Actinium Pharmaceuticals
ATNM
$24.2M
$6K ﹤0.01%
+544
New +$9.28K
MUR icon
3457
CALL
Murphy Oil
MUR
$5.09B
$6K ﹤0.01%
12,600
+2,200
+21% +$67.4K
PGR icon
3458
CALL
Progressive
PGR
$124B
$6K ﹤0.01%
12,100
-300
-2% -$20K
IMBI
3459
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$6K ﹤0.01%
1,430
– –
AMPE
3460
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
53
-208
-80% -$31.9K
CJ
3461
CALL
DELISTED
C&J Energy Services, Inc.
CJ
$6K ﹤0.01%
25,000
– –
IYR icon
3462
CALL
iShares US Real Estate ETF
IYR
$4.52B
$5K ﹤0.01%
+11,800
New +$927K
SGYP
3463
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$5K ﹤0.01%
43,718
-93,035
-68% -$61K
GCVRZ
3464
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5K ﹤0.01%
11,015
+12
+0.1% +$6
BAC icon
3465
CALL
Bank of America
BAC
$447B
$4K ﹤0.01%
85,800
-13,700
-14% -$372K
CLDX icon
3466
Celldex Therapeutics
CLDX
$3.37B
$4K ﹤0.01%
1,416
– –
CVX icon
3467
CALL
Chevron
CVX
$382B
$4K ﹤0.01%
50,400
-16,500
-25% -$1.91M
GSK icon
3468
CALL
GSK
GSK
$104B
$4K ﹤0.01%
62,880
-960
-2% -$47.3K
MET icon
3469
CALL
MetLife
MET
$61.7B
$4K ﹤0.01%
47,500
-500
-1% -$21.5K
SFM icon
3470
CALL
Sprouts Farmers Market
SFM
$7.96B
$4K ﹤0.01%
77,700
-600
-0.8% -$15.6K
BP icon
3471
CALL
BP
BP
$110B
$3K ﹤0.01%
120,924
+27,604
+30% +$1.1M
GDX icon
3472
PUT
VanEck Gold Miners ETF
GDX
$27.6B
$3K ﹤0.01%
+63,000
New +$1.24M
GE icon
3473
CALL
GE Aerospace
GE
$380B
$3K ﹤0.01%
4,486
– –
GILD icon
3474
CALL
Gilead Sciences
GILD
$165B
$3K ﹤0.01%
23,600
-13,600
-37% -$951K
TECK icon
3475
CALL
Teck Resources
TECK
$32.8B
$3K ﹤0.01%
11,200
-11,700
-51% -$254K
137 138
139
140 141

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.